1. Evaluation of Platinum Anticancer Drug-Induced Kidney Injury in Primary Culture of Rat Kidney Tissue Slices by Using Gas-Permeable Plates
   Hiroshi Arakawa et al, 2022, Biological and Pharmaceutical Bulletin CrossRef
2. Drug susceptibility testing of circulating lung cancer cells for personalized treatment
   Ajay Balakrishnan et al, 2022, Medical Oncology CrossRef
3. Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom
   Shelby Barnett et al, 2021, British Journal of Clinical Pharmacology CrossRef
4. Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments
   Chiara Lago et al, 2023, EMBO Molecular Medicine CrossRef
5. Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis
   Nan Zhang et al, 2023, OncoTargets and Therapy CrossRef
6. High-grade serous ovarian carcinoma in a patient with end-stage renal disease
   Selena Gajic et al, 2024, Vojnosanitetski pregled CrossRef
7. Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report
   Masahiro Kondo et al, 2018, Journal of Pharmaceutical Health Care and Sciences CrossRef
8. Synergistic Antitumor Interaction of Risedronate Sodium and Standard Anticancer Agents in Canine (D-17) and Human Osteosarcoma (U-2 OS) Cell Lines
   Dominik Poradowski et al, 2022, Animals CrossRef